Londn The British company AstraZeneca announced that it has suspended the final phase of a clinical trial of coronavirus vaccine, which it is developing in collaboration with scientists from Oxford University, after one of the participants showed unexplained health problems. Reuters reported.
<!—->
Volunteers want to become infected with coronavirus because of their vaccination. 37 thousand of them signed up |
The company’s spokeswoman Michele Meixellov clarified that the decision had been made voluntarily, according to standard practice, and added that the circumstances of the commission were now independent of the assessment. A clinical study of coronavirus vaccines developed by AstraZeneca and Oxford University has been conducted in several cities. Health complications occurred in a participant in the United Kingdom. It is not clear how the problems are, or when they manifested themselves. According to the Stat News website, it is expected that a participant in a study suspected of having an adverse reaction is recovering.
Stat News reported that the suspension of clinical trials had an impact on other AstraZeneca trials and clinical trials conducted by other pharmaceutical companies. AstraZeneca said in a statement that in large studies, the disease can manifest itself by accident, but it is necessary to examine the circumstances independently.
Uspchn vvoje vakcny na koronavirus by se nemuselo vyplatit, varuj britt vdci |
Shares of AstraZeneca first fell by more than eight percent, while its competitors saw growth in the vaccine. American Modern wrote a percentage, Pfizer me not a percentage.
Nine American and European vaccine developments have now committed to adhering to the scientific safety standards of their experimental vaccines. The review was issued due to growing concerns that safety standards will not be fully met during vaccination studies due to political pressure to quickly deliver vaccines to the market.
–
<!—->
–
– .
